A Third Major Locus for Autosomal Dominant Hypercholesterolemia Maps to 1p34.1-p32-Reference-Cited by-同舟云学术

A Third Major Locus for Autosomal Dominant Hypercholesterolemia Maps to 1p34.1-p32

Published:1999-05 Issue:5 Volume:64 Page:1378-1387
ISSN:0002-9297
Container-title:The American Journal of Human Genetics
language:en
Short-container-title:The American Journal of Human Genetics

Author:

Varret Mathilde,Rabès Jean-Pierre,Saint-Jore Bruno,Cenarro Ana,Marinoni Jean-Christophe,Civeira Fernando,Devillers Martine,Krempf Michel,Coulon Monique,Thiart Rochelle,Kotze Maritha J.,Schmidt Helena,Buzzi Jean-Claude,Kostner Gert M.,Bertolini Stephano,Pocovi Miguel,Rosa Alberto,Farnier Michel,Martinez Maria,Junien Claudine,Boileau Catherine

Publisher

Elsevier BV

Subject

Genetics (clinical),Genetics

Reference36 articles.

1. Niveles de colesterol y triglicéridos y distribucion del colesterol en lipoproteinas en una poblacion laboral: Varones (I);Civeira;Clin Invest Arteriosclerosis,1990

2. A second locus for Marfan syndrome maps to chromosome 3p24.2-p25;Collod;Nat Genet,1994

3. The Généthon human genetic linkage map;Dib;Nature,1996

4. Exclusion mapping;Edwards;J Med Genet,1987

5. Binding and degradation of low density lipoproteins by cultured human fibroblasts: comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia;Goldstein;J Biol Chem,1974

Cited by 152 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The singular French PCSK9-p.Ser127Arg gain-of-function variant: a significant player in cholesterol levels from a 775-year-old common ancestor;Atherosclerosis;2024-09

2. Global trends and research hotspots of PCSK9 and cardiovascular disease: a bibliometric and visual analysis;Frontiers in Cardiovascular Medicine;2024-06-03

3. Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): from bench to bedside;Signal Transduction and Targeted Therapy;2024-01-08

4. A Case Report of Hemochromatosis Secondary to Severe Hyperlipidemia and Review of Relevant Literature;Advances in Clinical Medicine;2024

5. A bibliometric analysis of PCSK9 inhibitors from 2007 to 2022;Frontiers in Endocrinology;2023-11-29